VIMPAT 200 MG TABLET

lacosamide
$19.6636per EA
High Outlier
DEA Schedule CV

Strength

200 mg/1

Manufacturer

UCB, Inc.

NDC

00131248060

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

1/1/2026

Active Ingredients

LACOSAMIDE

Approval Type

New Drug (NDA)

FDA Application

NDA022253

On Market Since

5/26/2009

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+2.6%

1Y

+2.7%

3Y

+9.7%

5Y

+24.3%

All

+117.2%